These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37525932)

  • 1. The effect of anamorelin (ONO-7643) on cachexia in cancer patients: Systematic review and meta-analysis of randomized controlled trials.
    Rezaei S; de Oliveira LC; Ghanavati M; Shadnoush M; Akbari ME; Akbari A; Hadizadeh M; Ardehali SH; Wakabayashi H; Elhelali A; Rahmani J
    J Oncol Pharm Pract; 2023 Oct; 29(7):1725-1735. PubMed ID: 37525932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anamorelin for cancer anorexia-cachexia syndrome: a systematic review and meta-analysis.
    Bai Y; Hu Y; Zhao Y; Yu X; Xu J; Hua Z; Zhao Z
    Support Care Cancer; 2017 May; 25(5):1651-1659. PubMed ID: 28074289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study.
    Garcia JM; Friend J; Allen S
    Support Care Cancer; 2013 Jan; 21(1):129-37. PubMed ID: 22699302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials.
    Garcia JM; Boccia RV; Graham CD; Yan Y; Duus EM; Allen S; Friend J
    Lancet Oncol; 2015 Jan; 16(1):108-16. PubMed ID: 25524795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anamorelin for advanced non-small-cell lung cancer with cachexia: Systematic review and meta-analysis.
    Nishie K; Yamamoto S; Nagata C; Koizumi T; Hanaoka M
    Lung Cancer; 2017 Oct; 112():25-34. PubMed ID: 29191597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04).
    Katakami N; Uchino J; Yokoyama T; Naito T; Kondo M; Yamada K; Kitajima H; Yoshimori K; Sato K; Saito H; Aoe K; Tsuji T; Takiguchi Y; Takayama K; Komura N; Takiguchi T; Eguchi K
    Cancer; 2018 Feb; 124(3):606-616. PubMed ID: 29205286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anamorelin for cancer cachexia.
    Nishie K; Sato S; Hanaoka M
    Drugs Today (Barc); 2022 Mar; 58(3):97-104. PubMed ID: 35274629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of anamorelin in patients with cancer cachexia: Post-hoc subgroup analyses of a placebo-controlled study.
    Takayama K; Takiguchi T; Komura N; Naito T
    Cancer Med; 2023 Feb; 12(3):2918-2928. PubMed ID: 36394148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial.
    Takayama K; Katakami N; Yokoyama T; Atagi S; Yoshimori K; Kagamu H; Saito H; Takiguchi Y; Aoe K; Koyama A; Komura N; Eguchi K
    Support Care Cancer; 2016 Aug; 24(8):3495-505. PubMed ID: 27005463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials.
    Temel JS; Abernethy AP; Currow DC; Friend J; Duus EM; Yan Y; Fearon KC
    Lancet Oncol; 2016 Apr; 17(4):519-531. PubMed ID: 26906526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and safety of anamorelin for patients with cancer-related anorexia/cachexia syndrome: a systematic review and meta-analysis.
    Taniguchi J; Mikura S; da Silva Lopes K
    Sci Rep; 2023 Sep; 13(1):15257. PubMed ID: 37709824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in patients with cancer cachexia and low body mass index.
    Naito T; Uchino J; Kojima T; Matano Y; Minato K; Tanaka K; Mizukami T; Atagi S; Higashiguchi T; Muro K; Takayama K; Furuse J; Morishima E; Takiguchi T; Tamura K
    Cancer; 2022 May; 128(10):2025-2035. PubMed ID: 35195274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging role of anamorelin hydrochloride in the management of patients with cancer anorexia-cachexia.
    Currow DC; Skipworth RJ
    Future Oncol; 2017 Aug; 13(20):1767-1783. PubMed ID: 28621564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anamorelin in Japanese patients with cancer cachexia: an update.
    Wakabayashi H; Arai H; Inui A
    Curr Opin Support Palliat Care; 2023 Sep; 17(3):162-167. PubMed ID: 37389636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological management of cachexia in adult cancer patients: a systematic review of clinical trials.
    Advani SM; Advani PG; VonVille HM; Jafri SH
    BMC Cancer; 2018 Nov; 18(1):1174. PubMed ID: 30482179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC.
    Zhang H; Garcia JM
    Expert Opin Pharmacother; 2015 Jun; 16(8):1245-53. PubMed ID: 25945893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The regulatory approval of anamorelin for treatment of cachexia in patients with non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer in Japan: facts and numbers.
    Wakabayashi H; Arai H; Inui A
    J Cachexia Sarcopenia Muscle; 2021 Feb; 12(1):14-16. PubMed ID: 33382205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia.
    Currow D; Temel JS; Abernethy A; Milanowski J; Friend J; Fearon KC
    Ann Oncol; 2017 Aug; 28(8):1949-1956. PubMed ID: 28472437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plain language summary of a clinical study: anamorelin for treatment of Japanese people with non-small cell lung cancer and cachexia.
    Takayama K
    Future Oncol; 2024 Jun; ():1-11. PubMed ID: 38868904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Anamorelin, a Novel Non-Peptide Ghrelin Analogue, in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) and Cachexia-Review and Expert Opinion.
    Currow DC; Maddocks M; Cella D; Muscaritoli M
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.